Skip to main content

Table 1 Baseline characteristics by diabetes status

From: Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study

 

Without diabetes

(n = 2989)

With diabetes

(n = 3989)

P value

Age, years

60.8 ± 9.7

64.4 ± 9.5

< 0.001

Women, n (%)

1038 (34.7)

1528 (38.3)

0.002

Body mass index, kg/m2

24.2 ± 2.9

24.6 ± 3.1

< 0.001

Systolic blood pressure, mmHg

130.1 ± 17.7

131.7 ± 17.9

< 0.001

Diastolic blood pressure, mmHg

80.4 ± 11.3

80.0 ± 11.0

0.073

Total cholesterol, mg/dL

203.7 ± 40.1

201.5 ± 44.6

0.030

Fasting glucose, mg/dL

94.0 (86.0–102.0)

106.0 (92.0–131.0)

< 0.001

Clinical diagnosis, n (%)

 Myocardial infarction

1565 (52.4)

1946 (48.8)

0.003

 Unstable angina

1424 (47.6)

2043 (51.2)

Smoking status, n (%)

 Never

1745 (58.4)

2463 (61.7)

< 0.001

 Former

429 (14.3)

630 (15.8)

 Current

815 (27.3)

896 (22.5)

Alcohol consumption, n (%)

 Low

2032 (68.0)

2996 (75.1)

< 0.001

 Middle

874 (29.2)

904 (22.7)

 High

83 (2.8)

89 (2.2)

Physical activity, n (%)

 Low

1007 (33.7)

1066 (26.7)

< 0.001

 Middle

1567 (52.4)

2366 (59.3)

 High

415 (13.9)

557 (14.0)

Household income, n (%)

 Lower 30%

611 (20.4)

921 (23.1)

0.030

 Mid 40%

996 (33.3)

1283 (32.2)

 Upper 30%

1382 (46.2)

1785 (44.7)

Comorbidities, n (%)

 Heart failure

376 (12.6)

830 (20.8)

< 0.001

 Stroke

445 (14.9)

967 (24.2)

< 0.001

Concurrent medication, n (%)

 ACEi or ARB

2166 (72.5)

3377 (84.7)

< 0.001

 Beta-blockers

2268 (75.9)

3383 (84.8)

< 0.001

 Calcium channel blocker

2120 (70.9)

3229 (80.9)

< 0.001

 Statin

2208 (73.9)

3382 (84.8)

< 0.001

 Antiplatelet agents

2056 (68.8)

3204 (80.3)

< 0.001

  1. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker